| 常用名 | 那他珠单抗 | CAS号 | 189261-10-7 |
|---|---|---|---|
| 价格 | ¥需询单/1g ¥需询单/1mg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: Natalizumab is a recombinant, humanized monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses[1]. 物理化学性质: CAS号:189261-10-7 常用中文名:那他珠单抗 常用英文名:Natalizumab 分子式:C46H80N14O16SSe 分子量:1196.237 密度:N/A 沸点:1231.4±75.0 °C at 760 mmHg 熔点:N/A 闪点:698.5±37.1 °C 储存条件:2-8°C,密闭,干燥 |